Related Experiment Video
Updated: Nov 28, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
Implication of regulatory networks of long noncoding RNA/circular RNA-miRNA-mRNA in diabetic cardiovascular diseases
Wei Xiong1, Mengran Yao1, Yuqiao Yang1
1Department of Anesthesiology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan province 650032, PR China.
Insights
Diabetic cardiovascular diseases (DCVDs) are a major health threat. This review explores how long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs) form networks that regulate DCVDs, offering potential for new diagnostics and treatments.
Area of Science:
- Biochemistry
- Genetics
- Cardiology
Background:
- Diabetic cardiovascular diseases (DCVDs) represent a significant global health challenge and economic burden, stemming from diabetes mellitus.
- Noncoding RNAs, including long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and microRNAs (miRNAs), are increasingly recognized for their roles in regulating complex biological processes.
- These noncoding RNAs, particularly lncRNAs and circRNAs, can function as competing endogenous RNAs (ceRNAs), modulating miRNA activity and subsequently impacting messenger RNA (mRNA) expression.
Purpose of the Study:
- This review aims to elucidate the mechanistic, pathological, and functional roles of lncRNA/circRNA-miRNA-mRNA networks in the development and progression of DCVDs.
- It seeks to consolidate current understanding of these intricate regulatory pathways.
- The review also highlights the potential of these networks for future therapeutic interventions and prognostic evaluations in DCVDs.
Main Methods:
- This review synthesizes existing research and literature on the involvement of lncRNA, circRNA, and miRNA in diabetic cardiovascular diseases.
- It focuses on the ceRNA hypothesis, where lncRNAs and circRNAs act as miRNA decoys or sponges.
- The analysis covers mechanistic insights, pathological contributions, and functional implications of these molecular interactions.
Main Results:
- lncRNA and circRNA molecules play critical roles in regulating gene expression within the context of DCVDs by interacting with miRNAs.
- These interactions form complex regulatory networks (lncRNA/circRNA-miRNA-mRNA axes) that significantly influence the pathophysiology of diabetic cardiovascular complications.
- Dysregulation within these networks contributes to the development and progression of DCVDs.
Conclusions:
- The lncRNA/circRNA-miRNA-mRNA regulatory networks are integral to the pathogenesis of diabetic cardiovascular diseases.
- Understanding these networks provides novel insights into the molecular mechanisms underlying DCVDs.
- Targeting these pathways holds promise for the development of innovative strategies for early detection, treatment, and prognosis of DCVDs.
Abstract:
Diabetic cardiovascular diseases (DCVDs) are the most common complications of diabetes mellitus and are considered to be one of the most important threats to global health and an economic burden. Long noncoding RNA (lncRNA), circular RNA (circRNA), and miRNA are a novel group of noncoding RNAs that are involved in the regulation of various pathophysiological processes, including DCVDs. Interestingly, both lncRNA and circRNA can act as competing endogenous RNA of miRNA, thereby regulating the expression of the target mRNA by decoying or sponging the miRNA. In this review, we focus on the mechanistic, pathological and functional roles of lncRNA/circRNA-miRNA-mRNA networks in DCVDs and further discuss the potential implications for early detection, therapeutic intervention and prognostic evaluation.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
MicroRNAs
MicroRNAs
Coronary Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

